James Italia

James Italia has a diverse work experience. James currently holds the position of Vice President of Commercial Development at BrickBio, Inc. where they co-invented a platform technology for therapeutic applications. Their role involves focusing on business strategy, operations, experimental design, and commercialization of the technology.

Before joining BrickBio, Italia was a Chemical Biology Ph.D Candidate at Boston College. During this time, they published peer-reviewed research articles and advised a team of undergraduate students. James also worked as an Undergraduate Researcher, assisting in the setup of a new biochemistry lab under Abhishek Chatterjee.

Italia also has experience at Tufts University, where they served as a Principal, Engagement Manager, and Consultant at Tufts Advisory Partners (TAP), providing pro bono consulting services to biotech companies. In these roles, they delivered sales ramp, pricing, and commercialization strategies, determined market segmentation to increase revenue, and identified market gaps for healthcare software companies.

Additionally, Italia worked as a Project Leader at Boston Scientific Advisors, where they provided independent pro bono consulting services. James also gained experience as a Protein Chemistry Researcher at Biogen Idec, conducting biochemical research projects and developing various techniques in protein purification and analysis.

Overall, Italia's work experience demonstrates their expertise in biotech consulting, protein chemistry, and commercialization strategies for therapeutic technologies.

James Italia completed their education at Boston College. From 2010 to 2014, they pursued a Bachelor of Science (BS) degree in Biochemistry. Subsequently, they went on to earn a Doctor of Philosophy (PhD) degree in Chemistry (Chemical Biology) from 2014 to 2019.